Suchergebnisse - "Cariou, Bertrand"

PubPharm (472)

321

Sotagliflozin as a potential treatment for type 2 diabetes mellitus

enthalten in: Expert opinion on investigational drugs | 2015

von Cariou, B. | Charbonnel, B.

322

Efficacy and safety of alirocumab in high cardiovascular risk patients with inadequately controlled hypercholesterolaemia on maximally tolerated doses of statins: the ODYSSEY COMBO II randomized controlled trial

enthalten in: European heart journal | 2015

von Cannon, C. | Cariou, B. | Blom, D. | +5

323

Clinical use of insulin degludec

enthalten in: Diabetes research and clinical practice | 2015

von Vora, J. | Cariou, B. | Evans, M. | +6

324

mTOR inhibitors and diabetes

enthalten in: Diabetes research and clinical practice | 2015

von Vergès, B. | Cariou, B.

325

Long-term effects of Roux-en-Y gastric bypass on postprandial plasma lipid and bile acids kinetics in female non diabetic subjects: A cross-sectional pilot study

enthalten in: Clinical nutrition | 2015

von De Giorgi, S. | Campos, V. | Egli, L. | +7

326

Role of PCSK9 beyond liver involvement

enthalten in: Current opinion in lipidology | 2015

von Cariou, B. | Si-Tayeb, K. | Le May, C.

327

Sotagliflozin as a potential treatment for type 2 diabetes mellitus

enthalten in: Expert opinion on investigational drugs | 2015

von Cariou, B. | Charbonnel, B.

328

Characterization of Autosomal Dominant Hypercholesterolemia Caused by PCSK9 Gain of Function Mutations and Its Specific Treatment With Alirocumab, a PCSK9 Monoclonal Antibody

enthalten in: Circulation / Cardiovascular genetics | 2015

von Hopkins, P. | Defesche, J. | Fouchier, S. | +39

329

A YOUNG MAN WHOSE LDL-CHOLESTEROL IS GREATER THAN 1.9 G/L

enthalten in: La revue du praticien | 2015

von Cariou, B.

330

PCSK9-deficiency does not alter blood pressure and sodium balance in mouse models of hypertension

enthalten in: Atherosclerosis | 2015

von Berger, J. | Vaillant, N. | Le May, C. | +6